Medicine FAQ
Frequently asked questions about medical research, healthcare, and health technology
Does semaglutide reduce alcohol consumption?
A phase 2 randomized controlled trial published in February 2025 found that low-dose semaglutide reduced alcohol craving, drinks per drinking day, and heavy drinking episodes compared to placebo. …
Read full answer in: GLP-1 Receptor Agonists in ASUD Treatment
How does semaglutide compare to naltrexone for alcohol use disorder?
The February 2025 UNC trial showed that despite using doses lower than standard weight loss dosing, semaglutide produced effect sizes exceeding those typically seen with naltrexone. Real-world data …
Read full answer in: GLP-1 Receptor Agonists in ASUD Treatment
Why are there so few medications approved for alcohol use disorder?
New therapies for alcohol use disorder have been approved at a rate of roughly one every 25 years. Only three medications (naltrexone, acamprosate, and disulfiram) are currently FDA-approved. This …
Read full answer in: GLP-1 Receptor Agonists in ASUD Treatment
Are GLP-1 drugs approved for treating alcohol addiction?
No. GLP-1 receptor agonists like semaglutide are currently FDA-approved only for type 2 diabetes, obesity, and obstructive sleep apnea. While early trial results are promising, larger clinical trials …
Read full answer in: GLP-1 Receptor Agonists in ASUD Treatment
Who won the 2025 Nobel Prize in Physiology or Medicine?
Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi were jointly awarded the 2025 Nobel Prize in Physiology or Medicine for their discoveries concerning peripheral immune tolerance. Their work …
What is peripheral immune tolerance?
Peripheral immune tolerance is the mechanism by which regulatory T cells prevent other immune cells from mistakenly attacking the body's own organs and tissues. This discovery, recognized by the 2025 …
Where can I read the Nobel Prize popular science explanation?
The Nobel Prize organization publishes a "Popular Science" document for each prize, providing an accessible, layman-friendly description of the winning discoveries. The 2025 Medicine prize popular …
How did Mary Brunkow find out she won the Nobel Prize?
Mary Brunkow initially ignored a call from Sweden, thinking it was spam. She learned about her Nobel Prize from an AP photographer who came to her Seattle home in the early hours of the morning to …
How much weight loss does amycretin achieve compared to Wegovy and Zepbound?
In Phase 1b/2a trials published in The Lancet, injectable amycretin delivered 24.3% average weight loss at the highest dose over 36 weeks, compared to 1.1% for placebo. This outperforms both Wegovy …
How does amycretin work differently from semaglutide (Ozempic/Wegovy)?
Amycretin is a dual-pathway drug that combines semaglutide's GLP-1 receptor activation with amylin receptor agonism. While semaglutide alone slows gastric emptying and reduces appetite through GLP-1 …
When will amycretin be FDA approved and available?
Amycretin's injectable version completed Phase 1b/2a trials in 2025, with Phase 3 trials expected to begin in 2026. Based on typical drug development timelines, FDA approval could come around …
What happens to Novo Nordisk when the Ozempic patent expires?
Ozempic's core US patent expires in December 2031, but Novo Nordisk has multiple defenses. Manufacturing GLP-1 compounds requires specialized peptide production capabilities and patented injection …
What does amycretin's dose-response data tell us about future trials?
The Phase 1b/2a data showed overlapping weight-loss curves across different dose groups (20 mg: -22.0%, 5 mg: -16.2%, 1.25 mg: -9.7%), suggesting amycretin may reach its maximum effect at relatively …
Can machine learning predict blood sugar responses to individual meals?
Machine learning models like XGBoost can predict certain aspects of postprandial glucose response, particularly the amplitude (how high blood sugar rises after eating). Using features such as meal …
Read full answer in: Modeling Glycemic Response with XGBoost
Why use Gaussian curve fitting for glucose response modeling?
Fitting each postprandial glucose response to a normalized Gaussian function simplifies the prediction problem from modeling an entire glucose curve to predicting just three parameters: amplitude (how …
Read full answer in: Modeling Glycemic Response with XGBoost
How much data do you need to predict glycemic responses accurately?
Sample size is one of the most critical factors in glucose prediction accuracy. A model trained on 112 standardized meals from 19 non-diabetic subjects achieved moderate amplitude prediction …
Read full answer in: Modeling Glycemic Response with XGBoost
What features matter most for predicting postprandial glucose response?
In XGBoost-based glucose prediction, 27 engineered features were used across multiple categories: meal composition (carbohydrates, protein, fat, and their interaction terms), participant …
Read full answer in: Modeling Glycemic Response with XGBoost
What is the best machine learning model for predicting glucose levels from meal data?
XGBoost is a strong choice for tabular health data because it handles mixed data types, provides built-in feature importance, and performs well without requiring massive datasets. For postprandial …
Read full answer in: Modeling Glycemic Response with XGBoost
How do I export Freestyle Libre 3 glucose data for custom analysis?
You cannot export data directly from the LibreLink app, but LibreView (Abbott's web platform) lets you download your glucose history as a CSV file. Log in at libreview.com, navigate to your glucose …
Can I combine CGM data with nutrition and workout data in Python?
Yes. By normalizing timestamps across data sources, you can merge glucose readings from LibreView with nutrition data from MacroFactor, sleep data from Sleep Cycle, and workout data from Garmin or …